Current Molecular Pharmacology achieves a 2025 CiteScore of 7.8
Published 10 July, 2026
On June 3, 2026, the CiteScore 2025 metrics were officially released. Current Molecular Pharmacology (CMP) achieved a CiteScore of 7.8, with 200 publications receiving 1,933 citations as of May 2026, reflecting a clear upward trajectory in the journal's citation performance and underscoring its steadily growing academic influence and international visibility.
In the Pharmacology category (within Pharmacology, Toxicology, and Pharmaceutics), CMP ranked 66 out of 328 in 2025, marking a consistent positive trend over the past three years. In the Drug Discovery category (same subject area), the journal ranked 37 out of 161, and in the Molecular Medicine category (within Biochemistry, Genetics, and Molecular Biology), it ranked 51 out of 179.
The editorial team extends its sincere gratitude to the global board members, reviewers, authors, and readers whose unwavering support has made this achievement possible. Looking ahead, CMP will continue to focus on cutting-edge research in molecular pharmacology, further enhancing its editorial standards and academic standing, with the aim of establishing itself as a competitively positioned international journal in the field.